Concepedia

D Demaria

DD

Statistics

Publications

5

Citations

122

H-Index

5

Active since

1996

Affiliations

Fox Chase Cancer Center(Current)

University of Pennsylvania

D Demaria is an author at Fox Chase Cancer Center specializing in pharmacology, medicine, and clinical pharmacology.

Publications per year

1996–1999

5

Publications

5

A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer.

Geoffrey R. Weiss, Italo Poggesi, Maria Teresa Rocchetti et al. · PubMed · 1998 · 32 citations

, , +10

Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day schedule

James Stevenson, D Demaria, D Reilly et al. · Cancer Chemotherapy and Pharmacology · 1999 · 29 citations

, , +8

Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion

James Stevenson, D Demaria, J Sludden et al. · Annals of Oncology · 1999 · 26 citations · Full text

, , +17

A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion

Luis Paz‐Ares, Robert L. Kunka, D Demaria et al. · British Journal of Cancer · 1998 · 23 citations · Full text

, , +13

Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion.

Peter J. O’Dwyer, Paul B. Laub, D Demaria et al. · PubMed · 1996 · 12 citations

, , +15

1–5 of 5